Fulcrum Therapeutics Stock (NASDAQ: FULC) stock price, news, charts, stock research, profile.
You can purchase shares of Fulcrum Therapeutics (NASDAQ:FULC) through any online brokerage.
Other companies in Fulcrum Therapeutics’s space includes: Atea Pharmaceuticals (NASDAQ:AVIR), GH Research (NASDAQ:GHRS), Bioage Labs (NASDAQ:BIOA), Aquestive Therapeutics (NASDAQ:AQST) and Esperion Therapeutics (NASDAQ:ESPR).
Fulcrum Therapeutics has a consensus price target of $7.50.
The stock price for Fulcrum Therapeutics (NASDAQ: FULC) is $4.35 last updated December 20, 2024 at 4:01 PM EST.
There are no upcoming dividends for Fulcrum Therapeutics.
Fulcrum Therapeutics’s Q4 earnings are confirmed for Tuesday, February 25, 2025.
There is no upcoming split for Fulcrum Therapeutics.
Fulcrum Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.